1 / 33

IMMUNOPHARMACOLOGY

IMMUNOPHARMACOLOGY. Ma. Janetth B. Serrano, M.D., DPBA. IMMUNOPHARMACOLOGY. 2 major components of the immune system: INNATE Physical – skin, mucus membrane Biochemical – complement, lyzosyme Cellular – macrophages, neutrophils ADAPTIVE Antibodies – HUMORAL immunity

fraley
Télécharger la présentation

IMMUNOPHARMACOLOGY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IMMUNOPHARMACOLOGY Ma. Janetth B. Serrano, M.D., DPBA

  2. IMMUNOPHARMACOLOGY • 2 major components of the immune system: • INNATE • Physical – skin, mucus membrane • Biochemical – complement, lyzosyme • Cellular – macrophages, neutrophils • ADAPTIVE • Antibodies – HUMORAL immunity • T-lymphocyte – CELL MEDIATED immunity

  3. IMMUNOPHARMACOLOGY COMPLEMENTS in Innate Immunity: 1. C3a, C5a  chemotaxis 2. C3b  opsonization 3. C5b, C6, C7, C8, C9  MAC

  4. IMMUNOPHARMACOLOGY 0psonized bacteria Macrophage APC B lymphocyte T lymphocyte IL-4,IL-5 IL-2 IL-2 TH1 TH2 IFN- TNF- IFN- IFN- • Plasma Cells: • IgG - IgM • IgA - IgD Activated Macrophage Activated Cytotoxic T cell Activated NK cells Memory B Cells CELL-MEDIATED IMMUNITY HUMORAL IMMUNITY

  5. IMMUNOPHARMACOLOGY T-helper cells: 1. TH1 subset - IFN- , IL-2, TNF- 2. TH2 subset - IL-4, IL-5, IL-6, IL-10

  6. IMMUNOPHARMACOLOGY ABNORMAL IMMUNE RESPONSES: • HYPERSENSITIVITY • AUTOIMMUNITY • IMMUNODEFICIENCY

  7. Immunosuppressants IMMUNOPHARMACOLOGY 1. Corticosteroids 2. Cyclosporine 3. Sirolimus 4. Tacrolimus 5. Interferons 6. TNF-alpha binding drugs 7. Mycophenolate mofetil 8. 15-Deoxyspergualin 9. Thalidomide 10. Glatiramer

  8. Corticosteroids IMMUNOPHARMACOLOGY • MOA: • inhibit T-cell proliferation & T-cell dependent immunity • Inhibit expression of genes encoding cytokines • Inhibit production of inflammatory mediators • Affects cell-mediated immunity more than humoral immunity

  9. IMMUNOPHARMACOLOGY Corticosteroids • Continuous administration: • ↑ fractional catabolic rate of IgG • Indications: • Autoimmune disorders - autoimmune hemolytic anemia, LE - ITP, Inflammatory Bowel Dse,, Hashimoto’s • Modulate allergic reactions - asthma • Organ transplantation – rejection crisis

  10. IMMUNOPHARMACOLOGY Corticosteroids • Immunosuppressive dose: • 10-100 mg/day • Adverse effects: • GI bleeding • adrenal suppression • fluid retention • diabetes • proximal muscle wasting • superinfections

  11. IMMUNOPHARMACOLOGY Cyclosporin • Blocks T-cell activation • binds to cyclophillin  inhibits calcineurinactivity  inhibits gene transcription of IL-2, IL-3, IFN & other factors • Most commonly used immunosuppresant for renal transplantation • Indications: • transplant rejection (kidney, liver, pancreas, cardiac) • Autoimmune disorders (uveitis, RA, DM type1) • Toxicities: • nephrotoxicity, hyperglycemia, hyperlipidemia, osteoporosis, ↑ hair growth, transient liver dysfunction

  12. Tacrolimus IMMUNOPHARMACOLOGY • Binds to FK-binding protein  inhibits T-cell activation • 10-100 times more potent than cyclosporine • Liver & kidney transplant • Oral or IV : t½ = 9-12 hrs • Toxicity: • nephrotoxicity, neurotoxicity, hyperglycemia, GI dysfunction

  13. IMMUNOPHARMACOLOGY Sirolimus (rapamycin) • Binds also to immunophyllin  blocks the response of T-cell to cytokines • Potent inhibitor of B-cell proliferation & Ig production • Indications: • Kidney & heart allografts • C syclosporin  psoriasis & uveoretinitis

  14. IMMUNOPHARMACOLOGY Interferons • Type 1: induced by viral inf. • IFN-alpha  prod. by leukocytes • IFN-beta  fibroblasts & epithelial cells • Type 2: IFN-gamma  produced by activated T-lymphocytes • Indications: cancer • IFN-  multiple sclerosis • IFN- chronic granulomatous disease

  15. IMMUNOPHARMACOLOGY TNF-α binding drugs • INFLIXIMAB • Chimeric IgG1 monoclonal antibody with human region & murine regions • Suppress generation of cytokines • Crohn’s disease; RA • ETANERCEPT • Chimeric protein with human regiom • Similar MOA with infliximab but shorter half-life • RA

  16. IMMUNOPHARMACOLOGY Mycophenolate Mofetil • Inhibits a series of T & B lymphocyte responses • Inhibit de novo pathway of purine synthesis • Renal & heart transplantation • Mizoribine – inh. nucleotide synthesis PW; kidney transplants • Brequinar Sodium – inh. de novo pathway of pyrimidine synthesi; cancer & organ transplantation

  17. IMMUNOPHARMACOLOGY 15-Deoxyspergualin • Potent antimonocytic & antilymphocytic effect • Inhibits T & B lymphocyte response • Renal transplants; pancreas & heart transplants

  18. IMMUNOPHARMACOLOGY Thalidomide • Sedative drug • Favors TH2 over TH1 • Suppress TNF-α production • Antiangiogenesis action: teratogenicity & anticancer • Indications • Erythema nodosum leprosum (skin manifestations of SLE) • Lung transplantation

  19. IMMUNOPHARMACOLOGY Glatiramer • Relapsing-remitting form of multiple sclerosis • Subcutaneous injection • Toxicities: • Transient post-injection reaction

  20. IMMUNOPHARMACOLOGY CYTOTOXIC Agents: 1. Azathioprine 2. Leflunomide 3. Cyclophosphamide

  21. IMMUNOPHARMACOLOGY Azathioprine • Metabolized to 6-mercaptopurines • Inhibit purine synthesis interferes with nucleic acid metabolism  inhibits cellular & humoral responses • Highly teratogenic • Well absorbed from GI tract

  22. IMMUNOPHARMACOLOGY Azathioprine • Renal allograft, AGN, SLE(renal), RA, Crohn’s disease • Prednisone-resistant antibody-mediated ITP • Autoimmune hemolytic anemia • Toxicities: • Bone marrow suppression • GI disturbances: N&V, diarrhea • Skin rashes, drug fever, hepatic dysfunction

  23. IMMUNOPHARMACOLOGY Leflunomide • Prodrug of an inhibitor of pyrimidine synthesis • Inhibits lymphoid cells • Orally active • RA • Toxicities: • Headache, nausea & diarrhea • Hepatic dysfunction, renal impairment • Teratogenic

  24. IMMUNOPHARMACOLOGY Cyclophosphamide • Most potent immunosuppressive drug • Destroys proliferating lymphoid cells • Autoimmune disorders: SLE • Acquired factor XIII antibodies • Bleeding syndromes • Toxicities: • Pancytopenia, hemorrhagic cystitis

  25. Antibodies as Immunosuppressive Agents IMMUNOPHARMACOLOGY • Antilymphocytic antibody • Immune Globulin IV • Hyperimmune Immunoglobulins • Monoclonal Antibodies • Rho(D) Immune Globulin Micro-Dose • Prevention of hemolytic disease of the newborn • Given to mother within 72 hrs after delivery of an Rh-negative baby

  26. IMMUNOPHARMACOLOGY MONOCLONALANTIBODIES: 1.Muromonab- CD3 2. Palivizumab 3. Rituxumab 4.Trastuzumab

  27. IMMUNOPHARMACOLOGY Muromonab-CD3 • A T-cell specific antibody • Renal transplantation, heart / renal

  28. IMMUNOPHARMACOLOGY • Palivizumab – RSV • Rituximab – follicular B-cell non-hodgekins lymphma • Trastuzumab – metastatic breast CA

  29. IMMUNOMODULATORS • CYTOKINES • Interferon-alpha: - hairy cell leukemia - chronic myelogenous leukemia - malignant melanoma - Kaposi’s sarcoma - anticancer  renal cell CA, carcinoid syndrome, T cell leukemia

  30. IMMUNOMODULATORS • CYTOKINES

  31. IMMUNOPHARMACOLOGY IMMUNOPHARMACOLOGY IMMUNOMODULATORS • LEVAMISOLE: - antiparasitic agent - potentiate action of fluorouracil in adjuvant therapy of Dukes class C colorectal CA - other uses: > hodgkin’s lymphoma > RA

  32. IMMUNOPHARMACOLOGY IMMUNOPHARMACOLOGY IMMUNOMODULATORS • BCG (Bacille-Camille-Guarin): - immunization against tuberculosis - Adjuvant in intravesical therapy for SF bladder CA

  33. IMMUNOPHARMACOLOGY IMMUNOPHARMACOLOGY IMMUNOMODULATORS • HIV: - Inosiplex - Diethylcarbamate (DTC) • DiGeorge Syndrome of T cell deficiency - give THYMOSIN

More Related